Sherpa Healthcare Partners (the “Sherpa”) is an innovation-driven, value-oriented, specialized healthcare investor focusing on early- and growth-stage equity investments primarily in Greater China, as well as selectively in the U.S. and other jurisdictions. The “Sherpa” name is inspired by the Sherpa people, the mountain guides in the extreme altitudes of Mount Everest. Sherpas are renowned for their Wisdom, Expertise, Bravery, and Tenacity.
The core investment and management team of Sherpa (the “Team”) has worked together for over 13 years through at least six fund cycles , sharing the same values, mutual trust, and complementary capabilities. Each key member of the Team possesses over 10 years of investment and/or operational management experience, and Sherpa believes the Team is equipped with deep insights and strong connections within the healthcare industry.

Sherpa believes the Team has been widely recognized for its exceptional professionalism, deep expertise, and strong investment performance among the healthcare enterprise and investment communities. As of September 30, 2024, the Team had managed over US$1.9 billion with 160 portfolio companies since 2011 , focusing primarily on early- and growth-stage investments across all major healthcare subsectors including biotech/pharma, MedTech, diagnostics, healthcare services.





